Ireit - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
01/22/20	Phillip	Ireit	0.815	0.885	Accumulate	DDM

Interra Resources - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
10/10/19	SAC Advisors	Interra Resources	0.026	0.089	Buy	EV/IP reserves 6.4x
12/17/19	SAC Advisors	Interra Resources	0.065	0.089	Buy

Innotek - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
08/14/19	Lim & Tan	Innotek	0.5	0	Buy on weakness

Stock calls for 13 February 2020

Date	Analyst	Company	Last	Target	Call	Valuation
02/13/20	CIMB	CDL Hospitality	1.51	1.5	Hold	PB1x
02/13/20	Lim & Tan	DBS	25.42	0	Buy
02/13/20	CIMB	Far East Hospitality	0.67	0.64	Hold	DDM
02/13/20	Kim Eng	Genting	0.875	0.99	Buy	EV/Ebitda7x FY20
02/13/20	DMG & Partners	Genting	0.875	0.85	Neutral	EV/Ebitda7x FY20
02/13/20	CIMB	Genting	0.875	1	Add	EV/Ebitda8x CY21
02/13/20	DBS Vickers	Genting	0.875	1.1	Buy
02/13/20	UOB Kay Hian	Jumbo	0.335	0.32	Hold	PER21x FY20, Buy @ $0.29
02/13/20	DBS Vickers	Koufu	0.735	0.84	Buy	PER17x FY20
02/13/20	CIMB	OUE Commercial	0.525	0.53	Hold	DDM
02/13/20	DBS Vickers	Parkway Life	3.56	4	Buy	DCF
02/13/20	Kim Eng	Prime US Reit	1.02	1.1	Buy	DDM
02/13/20	UOB Kay Hian	Wing Tai	1.97	2.54	Buy

How do we know that the covid-19 virus is being contained?

If you do not trust the Chinese and western media, how do you know that the covid-19 virus is being contained?

Well, we can do a simple analysis of the published statistics to find out.

When we start to see the death toll keeps increasing but the total infected cases keep declining, we will know for certain that covid-19 virus is being contained.  Why is this inverse relationship important?

This is because the infected corpses will be cremated and this will provide no room for further transmission whilst the infected people are getting fewer.  However, we are not seeing this inverse relationship yet.  The current 2 statistics are telling us that the virus outbreak is not being contained yet.

https://www.worldometers.info/coronavirus/

Why many deaths will never appear in official figures?

https://www.asiaone.com/china/coronavirus-why-many-deaths-will-never-appear-official-figures

This article is published too late.

We had stated this more than 10 days ago.

http://sg-stock.blogspot.com/2020/02/what-happened-to-those-cities-under.html

Reuters manipulated the stocks with fake news.

https://sg.finance.yahoo.com/news/foxconn-says-recent-reuters-reports-015317442.html

Reuters didn't bother to get verifications from Foxconn about its resumption in China but went ahead to publish the fake news to prop up certain stocks.

Many investors are trapped in the stocks now because of Reuter's fake news.

Indofood Agri - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
03/01/19	DBS Vickers	Indofood Agri	0.2	0.19	Hold	DCF
04/12/19	DBS Vickers	Indofood Agri	0.28	0.19	Accept offer	offer price $0.28
05/02/19	DBS Vickers	Indofood Agri	0.28	0.19	Accept offer	offer price $0.28
07/16/19	DBS Vickers	Indofood Agri	0.325	0.33	Hold
08/05/19	DBS Vickers	Indofood Agri	0.32	0.29	Hold	DCF
12/10/19	DBS Vickers	Indofood Agri	0.33	0.29	Hold

IHH Healthcare - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
01/17/19	Kim Eng	IHH Healthcare	1.86	2.13	Buy	Sum of parts, Ringgit $6.45 target price
03/01/19	Kim Eng	IHH Healthcare	1.85	2.29	Buy	Sum of parts, Ringgit $6.90 target
05/31/19	UOB Kay Hian	IHH Healthcare	1.79	2.07	Buy	Ringgit $6.30 target price, PER32.8x FY2020
06/12/19	CIMB	IHH Healthcare	1.84	2.09	Add	Ringgit $6.37 target price
07/31/19	Kim Eng	IHH Healthcare	1.88	2.16	Buy	Sum of parts, Ringgit $6.50 target price
09/09/19	Kim Eng	IHH Healthcare	1.85	2.1	Hold	Sum of parts, Ringgit $6.30 target price
12/04/19	UOB Kay Hian	IHH Healthcare	1.74	1.94	Buy	Sum of parts, Ringgit $5.93 target price

IFS Capital - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
01/15/19	Amfrasers	IFS Capital	0.225	0.29	Buy	PB0.7x FY18
08/26/19	Amfrasers	IFS Capital	0.22	0.3	Outperform	PB0.6x FY20
11/14/19	Amfrasers	IFS Capital	0.225	0.3	Outperform	PB0.6x FY20
12/02/19	Amfrasers	IFS Capital	0.23	0.3	Outperform	PB0.6x FY20

Stock calls for 12 February 2020

Date	Analyst	Company	Last	Target	Call	Valuation
02/12/20	Phillip	APTV	0.167	0.165	Neutral	EV/Ebitda10x
02/12/20	UOB Kay Hian	Koufu	0.725	0.83	Buy
02/12/20	DBS Vickers	Lendlease Reit	0.91	1.05	Buy
02/12/20	Phillip	Micro-Mechanics	1.88	1.6	Reduce	PER15x FY20
02/12/20	DBS Vickers	Netlink	1	1.05	Buy	DCF
02/12/20	DMG & Partners	Oxley	0.34	0.42	Buy	RNAV (45% discount)
02/12/20	DMG & Partners	Unusual	0.2	0.38	Buy	DCF

The US and Germany are caught red-handed for spying globally.

https://www.bangkokpost.com/tech/1855834/us-german-spies-stole-global-secrets-via-swiss-encryption-firm

Hahaha! The US wants to accuse China of spying but itself is caught red-handed.

The US has been spying the world for decades with US-owned technologies.  Therefore, it cannot allow other technologies to be the mainstream infrastructures because it won't be able to continue to spy through other technologies.  Thus, the US-owned technologies represent a high cybersecurity risk which other countries must safeguard against to protect themselves.

The decoupling from US-owned technologies to open-sourced technologies is the right way to move forward.

The US has acknowledged that China cannot fulfill phase 1 deal.

https://finance.yahoo.com/news/coronavirus-could-impact-chinese-purchases-235616410.html

The US has acknowledged that China cannot fulfill phase 1 deal orders.

We had stated this numerous times on our blog.

http://sg-stock.blogspot.com/2020/02/china-has-acknowledged-that-it-cannot.html

Both the US and China have now acknowledged that phase 1 deal cannot be fulfilled.

Ifast Corp - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
02/21/19	DBS Vickers	Ifast Corp	1.11	1.19	Hold	DDM
04/30/19	DBS Vickers	Ifast Corp	1.12	1.05	Hold	DDM
07/30/19	DBS Vickers	Ifast Corp	1.1	1.05	Hold	DDM
11/01/19	DBS Vickers	Ifast Corp	1.01	1.05	Hold	DDM

Hyphens Pharma - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
07/03/19	DMG & Partners	Hyphens Pharma	0.196	0.25	Buy	DCF, PER12.2x FY19
08/20/19	DMG & Partners	Hyphens Pharma	0.2	0.25	Buy	DCF
10/15/19	DMG & Partners	Hyphens Pharma	0.199	0.25	Buy
11/08/19	SAC Advisors	Hyphens Pharma	0.195	0.285	Buy
11/20/19	DMG & Partners	Hyphens Pharma	0.21	0.25	Buy	DCF